© 2011 Genitourinary Publishing, Inc.
Volume 8, Number 2 Summer 2010
Treatment and Survival Among
Medicare Patients With Renal Cell Carcinoma
Christopher S. Hollenbeak, PhD
Rajiv Mallick, PhD
Erik Lehman, MS
Nasrollah Ghahramani, MD, MS
Carl T Reese, MD, MS
Management of Key Adverse Events Associated
With Everolimus Therapy
Nancy P. Moldawer, RN, MSN
Laura S. Wood, RN, MSN, OCN
Highlights from the 2010
American Society of Clinical Oncology Annual Meeting
June 4-8, 2010, Chicago, IL
To view this issue, click here.
Below are past issues of Kidney Cancer Journal. To view each issue, click on the link below the front cover. To see issues from previous years, click on the dates at the bottom of the page.
Each issue will be presented in a page-turning format, and by reading the directions to the left of the cover page, you will be able to go forward and backwards within the issue, enlarge and reduce pages, view the table of contents in the upper left, conduct a search of the entire issue
2010
by entering a key word in the upper right field, and print individual pages. Please note that slower internet connections will cause the pages to open, turn, and enlarge more slowly.
When you see an active hyperlink within the general text, an article (not the references) or in an ad unit, you can click that link to send an e-mail or be taken to that web page.
To view past issues from other years, click on one of the years below.
Volume 8, Number 1 Spring 2010
Targeting the PD-1/PD-L1 Pathway:
A Novel Approach to Immunotherapy in
Metastatic Renal Cell Carcinoma
Jacalyn Rosenblatt, MD and David F. McDermott, MD
Pulmonary Toxicity of the
Rapamycin Analog Class of mTOR Inhibitors
Gary Hudes, MD
To view this issue, click here.
Volume 8, Number 3 Autumn 2010
Vaccine Development in Renal Cell Carcinoma:
Is There a Future?
Katarina Luptakova, MD
David E. Avigan, MD
ABSTRACTS
9th International Kidney Cancer Symposium
From Early Detection to New Data on Combination Treatment, Abstracts from the Kidney Cancer Association Meeting Offer Current Insights on Renal Cancer
To view this issue, click here.
Volume 8, Number 4 Winter 2011
Hypertension as a Biomarker for Anti-VEGF Efficacy:
Incidence, Mechanisms, and Association With Clinical Outcome
Brian I. Rini, MD
High-Dose Interleukin-2 for the Treatment of Renal Cell
Carcinoma: Managing Toxicities for Better Outcomes
Janice P. Dutcher, MD
To view this issue, click here.
